Pharmacy Interventions to Improve Access to Medications for Opioid Use Disorder

On September 8, 2022, FORE convened an advisory meeting in New York City to identify the barriers that patients with opioid use disorder (OUD) commonly face in filling their prescriptions for medications for OUD (MOUD), focusing in particular on access to buprenorphine. The participants considered ways to change pharmacy delivery models as well as state and federal policies, regulations, and pharmacy payments to make it easier for people to fill their buprenorphine prescriptions.